Target disease and target populations for 21st century vaccine developmentIncluded in the list are the agents of infectious diseases for which vaccines.

Slides:

Advertisements

Similar presentations

Vaxil BioTherapeutics Ltd.

Advertisements

Future challenges for clinical care of an ageing population infected with HIV: a modelling study Dr Mikaela Smit, PhD, Kees Brinkman, MD, Suzanne Geerlings,

The expressions of H19 and Igf1r are significantly decreased in the eutopic endometrium of women with endometriosis compared to those without endometriosis.

Effects of inhibiting inflammatory cell recruitment on fracture healing Treatment with CCR2 antagonist, INCB3344, led to impaired fracture healing compared.

Induction of mPer1 mRNA expression by prostaglandin E2 (PGE2) in NIH3T3 cells. Induction of mPer1 mRNA expression by prostaglandin E2 (PGE2) in NIH3T3.

Figure 1 Role of innate lymphoid cells (ILCs) in steady state,

EULAR Lupus Nephritis Trials Network Study Group 2017

Figure 5 Schematic illustration of different clinical trial designs

Yeast containing pICC10 (Tir) and pICC267 (CK18) and pTY474S and pICC267 demonstrated an approximately 12.5‐fold increase in β‐galactosidase activity compared.

Kenneth L. Scott, Scott Powers Cancer Cell

Location of IL‐17‐producing cell types.

Reverse cholesterol transport is enhanced after systemic miR‐33 silencing.C57BL/6 mice (n = 7) were infused i.v. with 5 mpk scrambled or anti‐miR‐33 oligonucleotides.

AAV8‐hAAT‐FGF21 treatment improves liver fibrosis

CAR T cell dose and percentages of CAR‐positive cells within CAR T cell products CAR T cell dose and percentages of CAR‐positive cells within CAR T cell.

TR suppresses the assembly of NLRP3 inflammasome

Nat. Rev. Nephrol. doi: /nrneph

Patients with Kawasaki disease but not those with mimicking conditions have significantly elevated serum and urine levels of meprin A and filamin C, which.

Phenogenetic networks of genes linked to Alzheimer's and Parkinson's disease reveal concordant phenotypes Phenogenetic networks of genes linked to Alzheimer's.

The increasing availability of quantitative biological data from the human genome project, coupled with advances in instrumentation, reagents, methodologies,

Clinical testing of calcineurin inhibitors cyclosporine A and tacrolimus in autoimmune disorders Clinical testing of calcineurin inhibitors cyclosporine.

HSPC and T‐cell transduction

[68Ga]Pentixafor PET/CT and [18F]FDG PET/CT A–DMaximum intensity projections (MIP) of [68Ga]Pentixafor (A) and [18F]FDG PET/CT (B) of a 68‐year‐old male.

Modules with causal links to ALS are associated with inflammation and enriched with TDP‐43 protein–protein interactions (PPIs)‏ Modules with causal links.

Expression of PD‐1 on PBMC and malignant exudate T cells

Integrated protein co‐expression and differential expression across the ALS‐FTD disease continuum Integrated protein co‐expression and differential expression.

Identification of miR‐499 targets

Effect of VEGFA on ALDH+ population maintenance

PD‐L1 silencing in antigen presenting DCs results in hyperactivated pro‐inflammatory TCRhigh CD8+ T cells. PD‐L1 silencing in antigen presenting DCs results.

BET and MEK inhibition synergistically impair cell cycle regulation and activate apoptotic signaling BET and MEK inhibition synergistically impair cell.

Combination of OTX‐015 and PD does not induce overt toxicity

PERK activator treatment protects neurite network

Dietary administration of DHEA reduces jet‐lag

Astrocyte and microglial markers associated with neuroinflammation are increased across the ALS‐FTD spectrum Astrocyte and microglial markers associated.

Targeting AMPK in prostate cancerMT 63–78 (green burst) binds to the β1 subunit of AMPK, activating its enzymatic function. Targeting AMPK in prostate.

Diversity of methods utilized to model neurological diseases using patient‐derived iPSCs Diversity of methods utilized to model neurological diseases using.

Schematic diagram of the proposed model depicting the functional relationship between EGFR and FASN in TKI resistance within EGFR mutant NSCLC cells Schematic.

PolyQ‐huntingtin accelerates EMT. A

Patient organoids respond more diverse to drugs and with lower therapeutic potential than 2D cultured patient cells Patient organoids respond more diverse.

Timecourse of the outbreak.

The history of EMT in cancer.

Antibacterial drug discovery in the 21st century

IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice ARepresentative.

LV.IDS and LV.IDS.ApoEII improve brain‐specific IDS activity and express supra‐physiological levels of active IDS in peripheral organs LV.IDS and LV.IDS.ApoEII.

Kenneth L. Scott, Scott Powers Cancer Cell

Inhibition of NAMPT using the potent inhibitor FK866 sensitizes additional tumour cells to olaparib.A‐E.Sensitivity of the cell lines MDAMB468 (A), SUM149.

Association of total disease burden and disease progression with age‐adjusted blood heteroplasmy Association of total disease burden and disease progression.

Association of total disease burden with age, m

Vaccine protection against otitis media and sinusitis

Delivery of therapeutics to patients.

Surface biotinylation and fate of TREM2

Simulation showing that the cell length variability of the entire population can mask abnormal cell length variability at a specific cell cycle period.

Gene targeting of the therapeutic EGFP/PGK‐FANCA donor in the AAVS1 locus of HD CD34+ cells Gene targeting of the therapeutic EGFP/PGK‐FANCA donor in the.

An integrated NHR network.

Scheme of FGF‐dependent regulation of TGFβ signaling in smooth muscle cells and endothelial cells Scheme of FGF‐dependent regulation of TGFβ signaling.

C266S laforin's effect on LD‐associated general defect in autophagy

The antitumor activity of olaparib in PDXs identifies a subset of PARPi‐sensitive tumors The antitumor activity of olaparib in PDXs identifies a subset.

Blood metabolites as biomarkers for mitochondrial diseases

Therapeutic role of TR in HFD‐established diabetic mice

Global and focused views of human interaction map.

Rescue of motor neurons from death The ventral root of the fifth lumbar segment (L5). Rescue of motor neurons from death The ventral root of the fifth.

Etifoxine modulation of T‐cell activity during EAE

Histological and mRNA analysis of the inflammatory cytokines in the vehicle‐ or etifoxine‐treated mice at onset of clinical symptoms.A–D.At day 10 p.i.,

miR‐132/ITPKB pathway assessment in human AD hippocampus

Dual‐recombinase fluorescence lineage tracing of EMT in KPF (FSF‐KrasG12D/+;Trp53frt/+;Pdx1‐Flp);αSMA‐Cre;R26Dual mice Dual‐recombinase fluorescence lineage.

Tissue‐specific differences in the levels of CoQ9, CoQ10, and DMQ9, and in the DMQ9/CoQ9 ratio after β‐RA treatment in Coq9R239X mice Tissue‐specific differences.

POLG defects cause degeneration of enhancer‐active regions of CNS

Expression analysis of splicing factor mRNAs in various GBM datasets

CNP520 treatment of male C57/BL6 mice for 8 weeks did not cause hair depigmentation CNP520 treatment of male C57/BL6 mice for 8 weeks did not cause hair.

Possible outcomes of therapeutic treatments using the spiral model.

Paradigm for the cycle of precision vaccinology.

Presentation transcript:

Target disease and target populations for 21st century vaccine developmentIncluded in the list are the agents of infectious diseases for which vaccines are not yet available or for which more effective vaccines would be beneficial. Target disease and target populations for 21st century vaccine developmentIncluded in the list are the agents of infectious diseases for which vaccines are not yet available or for which more effective vaccines would be beneficial. Also included are therapeutic vaccines for chronic infectious diseases, as well as non‐communicable pathologies such as autoimmune diseases, cancer, and allergy, some of which are in advanced clinical trials. Isabel Delany et al. EMBO Mol Med. 2014;6:708-720 © as stated in the article, figure or figure legend